Cancers, Vol. 15, Pages 1623: Routine EWS Fusion Analysis in the Oncology Clinic to Identify Cancer-Specific Peptide Sequence Patterns That Span Breakpoints in Ewing Sarcoma and DSRCT
Conclusions and future perspectives: our method allows interpretation of what peptides result from the in-frame translation of EWS fusion junctions. These sequences, coupled with HLA-peptide binding data, are used to identify potential sequences of cancer-specific immunogenic peptides for Ewing sarcoma or DSRCT patients. This information may also be useful for immune monitoring (e.g., circulating T-cells with fusion-peptide specificity) to detect vaccine candidates, responses, or residual disease.
Source: Cancers - Category: Cancer & Oncology Authors: Peter M. Anderson Zheng Jin Tu Scott E. Kilpatrick Matteo Trucco Rabi Hanna Timothy Chan Tags: Communication Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Cancer Vaccines | Desmoplastic Small Round Cell Tumor (DSRCT) | Ewing's Sarcoma | Genetics | Laboratory Medicine | Pathology | Sarcomas | Vaccines